Skip to main content

Elderly Patients with Type 2 Diabetes on Higher Risk of COVID-19 Death

Aged Patients with type 2 Diabetes face Higher Risk of COVID-19 death

he research team of the Central South Hospital of Wuhan University has found that age-related underlying diseases, such as hypertension and diabetes, can significantly slow down the rate of virus clearance in patients with COVID-19, especially the risk of death after the specific population of type 2 diabetes suffers from COVID-19 higher.

Among patients with COVID-19, those with cancer also have a higher risk of death. The research team of the Central South Hospital of Wuhan University has found that basic age-related diseases, such as hypertension and diabetes, will significantly slow down the rate of virus clearance in patients with COVID-19.

However, few studies have shown that diabetes, especially the specific population of type 2 diabetes, has a higher risk of death after suffering from COVID-19.

Recently, a study involving Monash University found that elderly diabetes patients with COVID-19 have a higher risk of dying from the disease-the virus may actually trigger diabetes attacks in normal healthy people. 

COVID-19 patients during a pandemic suffer from diabetes

The study, published in The Lancet Diabetes and Endocrinology, found that globally, 20% to 50% of patients diagnosed with COVID-19 during a pandemic suffer from diabetes. It also pointed out that among diabetics, especially elderly type 2 diabetics, the risk of dying from COVID-19 is 50% higher.

In Australia, as of April 12, one third of the 46 people who died of COVID-19 had diabetes, and 20% of the 752 hospitalized for viral infections had diabetes.

This study was completed by an international team of experts in the field of diabetes. They gathered together to provide guidance and practical advice on diabetes management for clinicians in developed and developing countries.

Co-author Paul Zimmet AO, professor of the Department of Diabetes at Monash University, is also the Honorary Chairman of the InternationalDiabetes Federation and has been providing advice to the Federal Minister of Health on the government’s National Diabetes Strategy.

Professor Zimmert said the data highlights the real threat of COVID-19 to diabetics because they are more likely to develop severe pneumonia and sepsis. This research is important because it brings together the current world impact of COVID-19 on diabetics, and given that this epidemic has occurred recently, they are at increased risk.

Diabetes patients with COVID-19 have Higher Death Risk

Epidemiological observations in areas severely affected by COVID-19, and reports from the Centers for Disease Control (CDC) and other national health centers and hospitals show that among patients with COVID-19, the fatal risk of diabetes is higher than that of patients without diabetes More than 50% higher.

Most of the focus of this study is on patients with type 2 diabetes

So far, most of the information has been concentrated on the relevant elderly population, and the risk of COVID-19 in young people with type 1 diabetes seems to be much lower. 

As long as they can guarantee adequate medical care and control their diabetes well. On this issue, the parents of children and adolescents have taken a heart-pill.

The study pointed out that damage to pancreatic beta cells (cells that make insulin) may cause direct damage to pancreatic function. Although this has not been confirmed in humans, researchers believe that diabetes may not only be a risk factor for severe COVID-19 disease, but infection may cause new-onset diabetes.

Patients with COVID-19 and diabetes risks, simulation

There is also evidence to support this finding in the potential islet β cell damage caused by the lack of insulin caused by the new coronavirus. 
Other co-authors have reported that severe diabetic ketoacidosis (DKA) often occurs during hospitalization.

COVID-19 Patients Should be Tested for Diabetes

Professor Zimmert said the study recommended that people with COVID-19 infection be tested for diabetes to identify whether previously healthy people had diabetes due to infection with the virus. Because this will obviously affect their medical management and health outcomes.

According to this study, patients with diabetes have an increased risk of serious complications, including adult respiratory distress syndrome and multiple organ failure including lung, heart, and kidney.

Professor Zimmert said that diabetes care professionals engaged in the care of patients with COVID-19 should also be warned to ensure that they have the protection they need to prevent infection.

Certain subgroups of diabetics may also require special attention, including:

(1) People who have poor control of diabetes metabolism (blood sugar)

(2) People with diabetes complications (overall, people with severe COVID-19 infection have a high risk of kidney failure)

(3) Obese type 2 diabetics (this may cause management problems)

(4) Diabetic patients undergoing bariatric surgery due to obesity (needs special attention)

(5) People who have undergone pancreas and kidney transplantation, or who have undergone regular dialysis

(6) Patients receiving immunosuppressive therapy or cortisone therapy for other diseases

(7) Those who take certain diabetes drugs (if they are seriously ill, it may affect the progress of the disease)

(8) Type 2 diabetes patients with hypertension and hyperlipidemia (fat) (it is important to continue to adopt appropriate blood pressure and lipid-lowering programs)








Comments

Popular posts from this blog

Difference Between COVID-19 Coronavirus and Other Flu Epidemic Infections

What are the differences between COVID-19 and the flu epidemic?The epidemic caused by the new Coronavirus (2019-nCoV) is still spreading. This disease, which has just been officially named COVID-19, has caused more than 40,000 infections and more than 1,000 deaths. At the same time, on the other side of the ocean, another epidemic also attracted people's attention. The flu season in the United States is on schedule. 
According to data released by the US Centers for Disease Control and Prevention, as of February 1, 22 million to 31 million people are expected to be infected during the flu season, and the number of patients dying from influenza is between 12,000 and 30,000. 
Seeing such figures, some readers may be surprised when they think: Is the flu epidemic in the United States worse? What are the differences between COVID-19 and the flu epidemic? Is this really the case? What are the differences between COVID-19 and the flu epidemic?
The facts are being unraveled below: 1. Unknown ris…

FDA Launches New Website to Encourage COVID-19 Rehabilitation Patients to Donate Plasma

According to foreign media TechCrunch, one of the ways currently being sought to develop effective treatments for COVID-19 is to use convalescent plasma. Basically, this means using plasma from COVID-19 patients who have fully recovered, hoping to transfer the antibodies they produced during the fight against the virus to others. 

US Food and Drug Administration (FDA) creates dedicated website to seek recovery plasma donationsThe US Food and Drug Administration (FDA) has created a dedicated new website that seeks recovery plasma donations from COVID-19 rehabilitation patients and explains their potential uses.
The use of plasma during recovery is hardly a new concept. In fact, it has been used since the late 1890s and was used during the Spanish influenza pandemic in 1918, although "the results were mixed."
Modern methods can help improve the efficacy and potential of recovered plasma as a therapeutic method. There are currently some drugs under development that use plasma (ani…

Considerations Before Electrocardiogram ECG Test